Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by <i>Mycobacterium avium</i> Complex (CONVERT). A Prospective, Open-Label, Randomized StudyDavid E. Griffith, Kevin Winthrop, Anne E. O’Donnell et al.|American Journal of Respiratory and Critical Care Medicine|2018Cited by 343
Proteinase 3 as a marker of clinical severity in bronchiectasis: Data from the EMBARC-BRIDGE studyEmma Johnson, James D. Chalmers, Megan Crichton et al.|Unknown|2023Cited by 2
Airway CD10/neprilysin is related to lung function and disease severity in patients with bronchiectasis: Preliminary data from the EMBARC BRIDGE studyHannah Dickson, James D. Chalmers, Rebecca C Hull et al.|Unknown|2025Cited by 0
Distinct IL-1β and TNF driven inflammatory responses in Non-typable Haemophilus influenzae infection in bronchiectasisJames D. Chalmers, Rebecca C Hull, Hollian Richardson et al.|Unknown|2025Cited by 0